NYU Langone Health: Antilupus Drug Prevents Low Heartbeat Condition in Newborns
July 14, 2020
July 14, 2020
NEW YORK, July 14 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
A drug used to treat systemic lupus erythematosus (SLE) significantly reduces the incidence of a rare and sometimes fatal heart condition in newborn babies, a new study from NYU Grossman School of Medicine researchers shows.
The condition, called congenital heart block (CHB), results in a lower than normal heart rate and affects as . . .
A drug used to treat systemic lupus erythematosus (SLE) significantly reduces the incidence of a rare and sometimes fatal heart condition in newborn babies, a new study from NYU Grossman School of Medicine researchers shows.
The condition, called congenital heart block (CHB), results in a lower than normal heart rate and affects as . . .